Keyphrases
Tumor
100%
Clinical Response
100%
In Cancer
100%
Clinical Resistance
100%
Immune Checkpoint Blockade
100%
Response Predictors
42%
Immune Suppression
28%
Immune Checkpoint
28%
Molecular Mechanism
14%
Clinical Trials
14%
Adaptive Immune Response
14%
Tumor Cells
14%
Dysregulation
14%
Solid Cancer
14%
Induction Therapy
14%
Self-tolerance
14%
Inhibitory Signaling
14%
Patient Response
14%
Immune System
14%
Tumor Immunity
14%
Blood Cancer
14%
Programmed Death-ligand 1 (PD-L1)
14%
Patient Identification
14%
Delayed Response
14%
Same Patient
14%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
14%
Multiple Lesions
14%
Functional Role
14%
Combinational Therapy
14%
Immune Activation
14%
Targeting Strategies
14%
Immune Destruction
14%
Antibody Therapy
14%
Immune Checkpoint Therapy
14%
Immune-related Adverse Events
14%
Immunogenic Tumor
14%
Second-line Agents
14%
Immune Self
14%
Medicine and Dentistry
Malignant Neoplasm
100%
Tumor
100%
Immune Checkpoint Blockade
100%
Cancer
28%
Neoplasm
14%
Clinical Trial
14%
Adverse Event
14%
Immunosuppressive Treatment
14%
Tumor Cell
14%
Adaptive Immunity
14%
Immunological Tolerance
14%
Cytotoxic T-Cell
14%
Tumor Immunity
14%
Immune System
14%
Programmed Cell Death
14%